Merck & Co (MRK) Earnings Date & Reports

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

MRK is expected to report earnings to rise 23.84% to $2.13 per share on April 24

Q1'25

Est.

$2.13

Q4'24

Missed

by $0.09

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.12

Q1'24

Beat

by $0.14

The last earnings report on February 04 showed earnings per share of $1.72, missing the estimate of $1.81. With 12.39M shares outstanding, the current market capitalization sits at 331.75B.

View a ticker or compare two or three

Compare

MRK